Measuring Care Utilization and Quality for Those with Chronic Kidney Disease by Payer and Community Vulnerability
Vizient, Inc. obtained certification from the Centers for Medicaid and Medicare Services (CMS) in 2022 to become a Qualified Entity (QE), allowing us to receive 100% of Medicare claims from all 50 states and the District of Columbia. As part of this certification, Vizient has published its first public report utilizing this data, in combination with other Vizient data resources, to provide measures of provider performance.
The measures evaluated in this report include data from 2019-2021 among patients with chronic kidney disease (CKD) and End-Stage Renal Disease (ESRD). CKD is a common and costly chronic disease in the US that can lead to ESRD when not managed effectively. In 2021, 37 million US adults had CKD and 786K had ESRD1.
Management of CKD and ESRD requires multidisciplinary care involving nephrologists, primary care providers, nurses, and other healthcare providers. The quality and timeliness of care provided to CKD and ESRD patients reflects the healthcare system's ability to coordinate and deliver comprehensive care. Increasing the amount of data available about healthcare encounters across the continuum of care for diverse CKD patient populations can help providers identify early interventions and preventive measures that slow down disease progression, potentially delaying or preventing the onset of ESRD.